NCT00558909View on ClinicalTrials.gov

4 Weeks Treatment of Type II Diabetic Patients With BI 44847

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 44847

DRUG

placebo for BI 44847

Trial Locations (4)

Unknown

1224.4.49002 Boehringer Ingelheim Investigational Site, Berlin

1224.4.49003 Boehringer Ingelheim Investigational Site, Mainz

1224.4.49001 Boehringer Ingelheim Investigational Site, Neuss

1224.4.31001 Boehringer Ingelheim Investigational Site, Zuidlaren

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY